HSBC Holdings’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.08M | Hold |
78,293
| – | – | ﹤0.01% | 1828 |
|
|
2025
Q4 | $1.1M | Sell |
78,293
-111,151
| -59% | -$1.56M | ﹤0.01% | 1881 |
|
|
2025
Q3 | $2.65M | Buy |
189,444
+97,884
| +107% | +$1.41M | ﹤0.01% | 1402 |
|
|
2025
Q2 | $1.38M | Hold |
91,560
| – | – | ﹤0.01% | 1641 |
|
|
2025
Q1 | $1.21M | Hold |
91,560
| – | – | ﹤0.01% | 1664 |
|
|
2024
Q4 | $1.45M | Sell |
91,560
-95,475
| -51% | -$1.43M | ﹤0.01% | 1618 |
|
|
2024
Q3 | $2.97M | Hold |
187,035
| – | – | ﹤0.01% | 1291 |
|
|
2024
Q2 | $2.85M | Sell |
187,035
-1,675
| -0.9% | -$24K | ﹤0.01% | 1262 |
|
|
2024
Q1 | $2.77M | Buy |
188,710
+27,000
| +17% | +$394K | ﹤0.01% | 1331 |
|
|
2023
Q4 | $2.25M | Hold |
161,710
| – | – | ﹤0.01% | 1441 |
|
|
2023
Q3 | $2.16M | Sell |
161,710
-86,945
| -35% | -$1.18M | ﹤0.01% | 1412 |
|
|
2023
Q2 | $3.14M | Buy |
248,655
+16,500
| +7% | +$193K | ﹤0.01% | 1246 |
|
|
2023
Q1 | $2.64M | Sell |
232,155
-45,300
| -16% | -$489K | ﹤0.01% | 1397 |
|
|
2022
Q4 | $2.87M | Buy |
277,455
+153,220
| +123% | +$1.65M | ﹤0.01% | 1523 |
|
|
2022
Q3 | $1.3M | Buy |
124,235
+5,500
| +5% | +$58.6K | ﹤0.01% | 1716 |
|
|
2022
Q2 | $1.31M | Hold |
118,735
| – | – | ﹤0.01% | 1787 |
|
|
2022
Q1 | $1.32M | Sell |
118,735
-190
| -0.2% | -$2.15K | ﹤0.01% | 1786 |
|
|
2021
Q4 | $1.56M | Sell |
118,925
-1,070
| -0.9% | -$13.5K | ﹤0.01% | 1795 |
|
|
2021
Q3 | $1.56M | Sell |
119,995
-11,000
| -8% | -$147K | ﹤0.01% | 1643 |
|
|
2021
Q2 | $1.93M | Sell |
130,995
-21,200
| -14% | -$296K | ﹤0.01% | 1461 |
|
|
2021
Q1 | $1.87M | Buy |
152,195
+78,375
| +106% | +$1.01M | ﹤0.01% | 1330 |
|
|
2020
Q4 | $1.05M | Sell |
73,820
-11,750
| -14% | -$158K | ﹤0.01% | 1667 |
|
|
2020
Q3 | $1.19M | Buy |
85,570
+14,550
| +20% | +$173K | ﹤0.01% | 1469 |
|
|
2020
Q2 | $753K | Sell |
71,020
-3,685
| -5% | -$37.5K | ﹤0.01% | 1593 |
|
|
2020
Q1 | $603K | Sell |
74,705
-100,150
| -57% | -$835K | ﹤0.01% | 1692 |
|
|
2019
Q4 | $1.42M | Buy |
174,855
+1,285
| +0.7% | +$10.1K | ﹤0.01% | 1651 |
|
|
2019
Q3 | $1.32M | Sell |
173,570
-32,390
| -16% | -$241K | ﹤0.01% | 1812 |
|
|
2019
Q2 | $1.54M | Buy |
205,960
+39,585
| +24% | +$311K | ﹤0.01% | 1625 |
|
|
2019
Q1 | $1.35M | Sell |
166,375
-9,105
| -5% | -$69.2K | ﹤0.01% | 1682 |
|
|
2018
Q4 | $1.32M | Buy |
175,480
+39,615
| +29% | +$279K | ﹤0.01% | 1659 |
|
|
2018
Q3 | $940K | Buy |
135,865
+8,110
| +6% | +$54.2K | ﹤0.01% | 1780 |
|
|
2018
Q2 | $822K | Sell |
127,755
-24,620
| -16% | -$155K | ﹤0.01% | 1864 |
|
|
2018
Q1 | $996K | Buy |
152,375
+835
| +0.6% | +$5.85K | ﹤0.01% | 1636 |
|
|
2017
Q4 | $1.14M | Sell |
151,540
-1,628,395
| -91% | -$11.7M | ﹤0.01% | 1260 |
|
|
2017
Q3 | $12.7M | Sell |
1,779,935
-1,413,015
| -44% | -$10.2M | 0.02% | 702 |
|
|
2017
Q2 | $26.9M | Sell |
3,192,950
-323,930
| -9% | -$2.63M | 0.05% | 415 |
|
|
2017
Q1 | $28.2M | Buy |
3,516,880
+335,150
| +11% | +$2.89M | 0.06% | 354 |
|
|
2016
Q4 | $28.8M | Buy |
3,181,730
+1,283,280
| +68% | +$11.9M | 0.07% | 354 |
|
|
2016
Q3 | $17.6M | Sell |
1,898,450
-66,010
| -3% | -$630K | 0.04% | 469 |
|
|
2016
Q2 | $20.1M | Sell |
1,964,460
-56,615
| -3% | -$519K | 0.06% | 410 |
|
|
2016
Q1 | $18.3M | Sell |
2,021,075
-262,515
| -11% | -$2.35M | 0.05% | 438 |
|
|
2015
Q4 | $21.1M | Buy |
2,283,590
+1,812,425
| +385% | +$19.8M | 0.05% | 419 |
|
|
2015
Q3 | $6.02M | Buy |
471,165
+44,925
| +11% | +$558K | 0.02% | 745 |
|
|
2015
Q2 | $4.72M | Buy |
426,240
+221,680
| +108% | +$2.45M | 0.01% | 843 |
|
|
2015
Q1 | $2.34M | Buy |
204,560
+38,665
| +23% | +$410K | ﹤0.01% | 1135 |
|
|
2014
Q4 | $1.68M | Buy |
165,895
+3,540
| +2% | +$37.3K | ﹤0.01% | 1201 |
|
|
2014
Q3 | $1.71M | Sell |
162,355
-534,690
| -77% | -$5.03M | ﹤0.01% | 1205 |
|
|
2014
Q2 | $6.01M | Buy |
697,045
+586,450
| +530% | +$4.93M | 0.01% | 796 |
|
|
2014
Q1 | $970K | Sell |
110,595
-12,510
| -10% | -$109K | ﹤0.01% | 1242 |
|
|
2013
Q4 | $1.01M | Sell |
123,105
-7,725
| -6% | -$61.1K | ﹤0.01% | 1265 |
|
|
2013
Q3 | $988K | Buy |
130,830
+10,945
| +9% | +$79.6K | ﹤0.01% | 1237 |
|
|
2013
Q2 | $907K | Buy |
+119,885
| New | +$875K | ﹤0.01% | 1095 |
|
Other funds holding RDY
AIM
HSBC Holdings's RDY Position: Q1 2026 in Review
HSBC Holdings held its Dr. Reddy's Laboratories (RDY) position steady in Q1 2026 at 78,293 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1828.
HSBC Holdings first reported a position in RDY in Q2 2013 and has held it in 52 quarters since. The position peaked at $28.8M in Q4 2016. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.
- HSBC Holdings held 78,293 shares of Dr. Reddy's Laboratories worth $1.08M as of Q1 2026.
- HSBC Holdings left its Dr. Reddy's Laboratories share count unchanged in Q1 2026.
- Dr. Reddy's Laboratories made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1828 holding.
- HSBC Holdings first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Dr. Reddy's Laboratories position peaked at $28.8M in Q4 2016.
- 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.